Abstract
The Hippo signaling pathway is widely considered a master regulator of organ growth because of the prominent overgrowth phenotypes caused by experimental manipulation of its activity. Contrary to this model, we show here that removing Hippo transcriptional output did not impair the ability of the mouse liver and Drosophila eyes to grow to their normal size. Moreover, the transcriptional activity of the Hippo pathway effectors Yap/Taz/Yki did not correlate with cell proliferation, and hyperactivation of these effectors induced gene expression programs that did not recapitulate normal development. Concordantly, a functional screen in Drosophila identified several Hippo pathway target genes that were required for ectopic overgrowth but not normal growth. Thus, Hippo signaling does not instruct normal growth, and the Hippo-induced overgrowth phenotypes are caused by the activation of abnormal genetic programs.
Original language | English |
---|---|
Pages (from-to) | eabg3679 |
Journal | Science |
Volume | 378 |
Issue number | 6621 |
DOIs | |
Publication status | Published - 18 Nov 2022 |
Bibliographical note
Funding Information:This work was supported by The Research Foundation Flanders (FWO Odysseus type I grant and project grants G.0954.16N and G.030616N to G.H. and an FWO doctoral fellowship to W.K.) and by the Cancer Prevention and Research Institute of Texas (grant RP200240 to R.J.).
Publisher Copyright:
© 2022 American Association for the Advancement of Science. All rights reserved.
Copyright:
Copyright 2022 Elsevier B.V., All rights reserved.
Keywords
- Animals
- Mice
- Drosophila melanogaster/embryology
- Drosophila Proteins/genetics
- Eye/embryology
- Gene Expression Regulation, Developmental
- Hippo Signaling Pathway/genetics
- Liver/embryology
- Organ Size
- Protein Serine-Threonine Kinases/genetics
- Trans-Activators/genetics
- Transcription, Genetic
- Transcriptional Coactivator with PDZ-Binding Motif Proteins/metabolism
- YAP-Signaling Proteins/metabolism